Cited by — Dual-time-point [18F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Dual-time-point [18F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy.
No admitted local citation edges point to this work yet.
